Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Losartan in Marfan Syndrome (MARFANSARTAN)
NCT00763893Phase 3Terminated
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- Sep 2008
- Primary completion
- Jan 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of losartan in Marfan syndrome (MFS), sponsored by Assistance publique - Hôpitaux de Paris. Started Sep 2008; status: terminated.
02
Drugs
losartan
03
Conditions
Marfan syndrome (MFS)
Beyond the preview
Go deeper on NCT00763893.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00763893.